Joinn Laboratories(China)Co.,Ltd.
603127
株式のランク
#3810
Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of... Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of preclinical and non-clinical services to clients across the United States, China, and other international regions. The company's business is organized into three core operational areas. Its Non-Clinical Studies Services segment focuses on drug safety assessment, drug metabolism and pharmacokinetics analysis, and pharmacology and efficacy investigations. The Clinical Trial and Related Services division offers contract research organization (CRO) support for clinical trials, co-manages Phase I clinical research units, and provides bioanalytical services. Furthermore, the Sales of Research Models segment is involved in the design, production, breeding, and distribution of various research models, including non-human primates and rodents. Beyond these offerings, Joinn Laboratories also provides investment management and cell-based assay (CBA) services. Founded in 1995, the company is headquartered in Beijing, China.
株価
$6.82
時価総額
$4.30B
変化（1日）
-6.30%
変化（1年）
48.79%
国
CN
取引 Joinn Laboratories(China)Co.,Ltd. (603127)
カテゴリー
Healthcare
Joinn Laboratories(China)Co.,Ltd.（603127）の株式分割履歴
Joinn Laboratories(China)Co.,Ltd.株（シンボル：603127）は合計で6回の株式分割を実施しました。
最新の株式分割はJul 25, 2023に行われました。
May 31, 2018より前に購入された603127株は、現在7.529536603127株に相当します。
最新の株式分割はJul 25, 2023に行われました。
May 31, 2018より前に購入された603127株は、現在7.529536603127株に相当します。
株式分割一覧
| 年 | 株式分割 | 分割比率 | 累積分割比率 |
|---|---|---|---|
| 2023-07-25 | 7:5 | x1.4 | x7.529536 |
| 2022-08-08 | 7:5 | x1.4 | x5.37824 |
| 2021-08-05 | 7:5 | x1.4 | x3.8416 |
| 2020-06-08 | 7:5 | x1.4 | x2.744 |
| 2019-04-10 | 7:5 | x1.4 | x1.96 |
| 2018-05-31 | 7:5 | x1.4 | x1.4 |
類似企業または競合他社の株式分割
| 企業 | 株式分割の回数 | 累積分割比率 | 国 |
|---|---|---|---|
| 8 | x34 |
US
|
|
| 7 | x47 |
US
|
|
| 0 | - |
US
|
|
| 3 | x2 |
CN
|
|
| 1 | x1 |
US
|
